Esperto Medical won a grant from the Translational Research Institute for Space Health to adapt its blood pressure sensor for spaceflight. The company did not disclose the amount.
The Fullerton, California company builds Resonance Sonomanometry, which pushes several acoustic frequencies into an artery and reads pressure directly. The method needs no calibration, which is the usual weak point in cuffless monitoring. TRISH wants continuous cardiovascular readings in microgravity, where fluid shifts make a cuff number hard to interpret.
Spaceflight is a tiny market on its own. What a grant like this buys an early company is human data under conditions no competitor has instrumented, paid for by somebody else, and a reviewer at FDA who has seen the accuracy claim stress tested.